APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Disease Management Services for the Elderly

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chronic Disease Management Services for the Elderly Market Outlook and Growth Opportunities 2026

6 March 2026191 pages

Choose your research edition.

Industry ResearchChronic Disease Management Services for the Elderly Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Disease Management Services for the Elderly Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Chronic Disease Management Services for the Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Disease Management Services for the Elderly Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Disease Management Services for the Elderly Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chronic Disease Management Services for the Elderly market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chronic Disease Management Services for the Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Disease Management Services for the Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Disease Management Services for the Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chronic Disease Management Services for the Elderly market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chronic Disease Management Services for the Elderly market include ALiHealth, Meinian Onehealth Healthcare, Pingan Health, CIMING CHEKUP, HealthSnap, ExlService Holdings, Health Catalyst, AllScripts Healthcare Solutions and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chronic Disease Management Services for the Elderly market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Disease Management Services for the Elderly and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Disease Management Services for the Elderly revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chronic Disease Management Services for the Elderly market.

Chronic Disease Management Services for the Elderly Segment by Company

ALiHealth

Meinian Onehealth Healthcare

Pingan Health

CIMING CHEKUP

HealthSnap

ExlService Holdings

Health Catalyst

AllScripts Healthcare Solutions

Koninklijke Philips

Chronic Disease Management Services for the Elderly Segment by Type

Online Services

Offline Services

Chronic Disease Management Services for the Elderly Segment by Application

Diabetic Patients

Asthmatic Patients

Hypertensive Patients

Other Patients

Chronic Disease Management Services for the Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chronic Disease Management Services for the Elderly status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chronic Disease Management Services for the Elderly key companies, revenue, market share, and recent developments.

3. To split the Chronic Disease Management Services for the Elderly breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chronic Disease Management Services for the Elderly market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chronic Disease Management Services for the Elderly significant trends, drivers, influence factors in global and regions.

6. To analyze Chronic Disease Management Services for the Elderly competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Management Services for the Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Management Services for the Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Management Services for the Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Disease Management Services for the Elderly industry.

Chapter 3: Detailed analysis of Chronic Disease Management Services for the Elderly company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chronic Disease Management Services for the Elderly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chronic Disease Management Services for the Elderly in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chronic Disease Management Services for the Elderly Industry Trends Table 2. Chronic Disease Management Services for the Elderly Industry Drivers Table 3. Chronic Disease Management Services for the Elderly Industry Opportunities and Challenges Table 4. Chronic Disease Management Services for the Elderly Industry Restraints Table 5. Global Chronic Disease Management Services for the Elderly Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chronic Disease Management Services for the Elderly Revenue Share by Company (2021-2026) Table 7. Global Chronic Disease Management Services for the Elderly Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chronic Disease Management Services for the Elderly Key Company Manufacturing Base & Headquarters Table 9. Global Chronic Disease Management Services for the Elderly Company, Product Type & Application Table 10. Global Chronic Disease Management Services for the Elderly Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chronic Disease Management Services for the Elderly by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Online Services Table 15. Significant Companies of Offline Services Table 16. Global Chronic Disease Management Services for the Elderly Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Chronic Disease Management Services for the Elderly Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Chronic Disease Management Services for the Elderly Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Chronic Disease Management Services for the Elderly Sales Value Share by Type (2021-2026) Table 20. Global Chronic Disease Management Services for the Elderly Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diabetic Patients Table 22. Significant Companies of Asthmatic Patients Table 23. Significant Companies of Hypertensive Patients Table 24. Significant Companies of Other Patients Table 25. Global Chronic Disease Management Services for the Elderly Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Chronic Disease Management Services for the Elderly Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Chronic Disease Management Services for the Elderly Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Chronic Disease Management Services for the Elderly Sales Value Share by Application (2021-2026) Table 29. Global Chronic Disease Management Services for the Elderly Sales Value Share by Application (2027-2032) Table 30. Global Chronic Disease Management Services for the Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chronic Disease Management Services for the Elderly Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Chronic Disease Management Services for the Elderly Sales Value Share by Region (2021-2026) Table 33. Global Chronic Disease Management Services for the Elderly Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Chronic Disease Management Services for the Elderly Sales Value Share by Region (2027-2032) Table 35. Global Chronic Disease Management Services for the Elderly Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Chronic Disease Management Services for the Elderly Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Chronic Disease Management Services for the Elderly Sales Value Market Share by Country (2021-2026) Table 38. Global Chronic Disease Management Services for the Elderly Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Chronic Disease Management Services for the Elderly Sales Value Market Share by Country (2027-2032) Table 40. ALiHealth Company Information Table 41. ALiHealth Business Overview Table 42. ALiHealth Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. ALiHealth Chronic Disease Management Services for the Elderly Product Portfolio Table 44. ALiHealth Recent Development Table 45. Meinian Onehealth Healthcare Company Information Table 46. Meinian Onehealth Healthcare Business Overview Table 47. Meinian Onehealth Healthcare Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Meinian Onehealth Healthcare Chronic Disease Management Services for the Elderly Product Portfolio Table 49. Meinian Onehealth Healthcare Recent Development Table 50. Pingan Health Company Information Table 51. Pingan Health Business Overview Table 52. Pingan Health Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Pingan Health Chronic Disease Management Services for the Elderly Product Portfolio Table 54. Pingan Health Recent Development Table 55. CIMING CHEKUP Company Information Table 56. CIMING CHEKUP Business Overview Table 57. CIMING CHEKUP Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. CIMING CHEKUP Chronic Disease Management Services for the Elderly Product Portfolio Table 59. CIMING CHEKUP Recent Development Table 60. HealthSnap Company Information Table 61. HealthSnap Business Overview Table 62. HealthSnap Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. HealthSnap Chronic Disease Management Services for the Elderly Product Portfolio Table 64. HealthSnap Recent Development Table 65. ExlService Holdings Company Information Table 66. ExlService Holdings Business Overview Table 67. ExlService Holdings Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ExlService Holdings Chronic Disease Management Services for the Elderly Product Portfolio Table 69. ExlService Holdings Recent Development Table 70. Health Catalyst Company Information Table 71. Health Catalyst Business Overview Table 72. Health Catalyst Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Health Catalyst Chronic Disease Management Services for the Elderly Product Portfolio Table 74. Health Catalyst Recent Development Table 75. AllScripts Healthcare Solutions Company Information Table 76. AllScripts Healthcare Solutions Business Overview Table 77. AllScripts Healthcare Solutions Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AllScripts Healthcare Solutions Chronic Disease Management Services for the Elderly Product Portfolio Table 79. AllScripts Healthcare Solutions Recent Development Table 80. Koninklijke Philips Company Information Table 81. Koninklijke Philips Business Overview Table 82. Koninklijke Philips Chronic Disease Management Services for the Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Koninklijke Philips Chronic Disease Management Services for the Elderly Product Portfolio Table 84. Koninklijke Philips Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Chronic Disease Management Services for the Elderly Product Image Figure 2. Global Chronic Disease Management Services for the Elderly Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Disease Management Services for the Elderly Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Disease Management Services for the Elderly Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Online Services Image Figure 8. Offline Services Image Figure 9. Global Chronic Disease Management Services for the Elderly Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Chronic Disease Management Services for the Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Chronic Disease Management Services for the Elderly Sales Value Share by Type (2021-2032) Figure 12. Diabetic Patients Image Figure 13. Asthmatic Patients Image Figure 14. Hypertensive Patients Image Figure 15. Other Patients Image Figure 16. Global Chronic Disease Management Services for the Elderly Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Chronic Disease Management Services for the Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Chronic Disease Management Services for the Elderly Sales Value Share by Application (2021-2032) Figure 19. Global Chronic Disease Management Services for the Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Chronic Disease Management Services for the Elderly Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Chronic Disease Management Services for the Elderly Sales Value (2021-2032) & (US$ Million) Figure 22. North America Chronic Disease Management Services for the Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Chronic Disease Management Services for the Elderly Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Chronic Disease Management Services for the Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Chronic Disease Management Services for the Elderly Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Chronic Disease Management Services for the Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Chronic Disease Management Services for the Elderly Sales Value (2021-2032) & (US$ Million) Figure 28. South America Chronic Disease Management Services for the Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Chronic Disease Management Services for the Elderly Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Chronic Disease Management Services for the Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Online Services
  • Offline Services
Applications
  • Diabetic Patients
  • Asthmatic Patients
  • Hypertensive Patients
  • Other Patients
Companies covered
  • ALiHealth
  • Meinian Onehealth Healthcare
  • Pingan Health
  • CIMING CHEKUP
  • HealthSnap
  • ExlService Holdings
  • Health Catalyst
  • AllScripts Healthcare Solutions
  • Koninklijke Philips

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Disease Management Services for the Elderly Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Disease Management Services for the Elderly Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chronic Disease Management Services for the Elderly Market Dynamics
  1. 2.1 Chronic Disease Management Services for the Elderly Industry Trends
  2. 2.2 Chronic Disease Management Services for the Elderly Industry Drivers
  3. 2.3 Chronic Disease Management Services for the Elderly Industry Opportunities and Challenges
  4. 2.4 Chronic Disease Management Services for the Elderly Industry Restraints
3 Chronic Disease Management Services for the Elderly Market by Company
  1. 3.1 Global Chronic Disease Management Services for the Elderly Company Revenue Ranking in 2025
  2. 3.2 Global Chronic Disease Management Services for the Elderly Revenue by Company (2021-2026)
  3. 3.3 Global Chronic Disease Management Services for the Elderly Company Ranking (2024-2026)
  4. 3.4 Global Chronic Disease Management Services for the Elderly Company Manufacturing Base and Headquarters
  5. 3.5 Global Chronic Disease Management Services for the Elderly Company Product Type and Application
  6. 3.6 Global Chronic Disease Management Services for the Elderly Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chronic Disease Management Services for the Elderly Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chronic Disease Management Services for the Elderly Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chronic Disease Management Services for the Elderly Market by Type
  1. 4.1 Chronic Disease Management Services for the Elderly Type Introduction
  2. 4.1.1 Online Services
  3. 4.1.2 Offline Services
  4. 4.2 Global Chronic Disease Management Services for the Elderly Sales Value by Type
  5. 4.2.1 Global Chronic Disease Management Services for the Elderly Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chronic Disease Management Services for the Elderly Sales Value by Type (2021-2032)
  7. 4.2.3 Global Chronic Disease Management Services for the Elderly Sales Value Share by Type (2021-2032)
5 Chronic Disease Management Services for the Elderly Market by Application
  1. 5.1 Chronic Disease Management Services for the Elderly Application Introduction
  2. 5.1.1 Diabetic Patients
  3. 5.1.2 Asthmatic Patients
  4. 5.1.3 Hypertensive Patients
  5. 5.1.4 Other Patients
  6. 5.2 Global Chronic Disease Management Services for the Elderly Sales Value by Application
  7. 5.2.1 Global Chronic Disease Management Services for the Elderly Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chronic Disease Management Services for the Elderly Sales Value by Application (2021-2032)
  9. 5.2.3 Global Chronic Disease Management Services for the Elderly Sales Value Share by Application (2021-2032)
6 Chronic Disease Management Services for the Elderly Regional Value Analysis
  1. 6.1 Global Chronic Disease Management Services for the Elderly Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Disease Management Services for the Elderly Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chronic Disease Management Services for the Elderly Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chronic Disease Management Services for the Elderly Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Disease Management Services for the Elderly Sales Value (2021-2032)
  7. 6.3.2 North America Chronic Disease Management Services for the Elderly Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chronic Disease Management Services for the Elderly Sales Value (2021-2032)
  10. 6.4.2 Europe Chronic Disease Management Services for the Elderly Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chronic Disease Management Services for the Elderly Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chronic Disease Management Services for the Elderly Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chronic Disease Management Services for the Elderly Sales Value (2021-2032)
  16. 6.6.2 South America Chronic Disease Management Services for the Elderly Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chronic Disease Management Services for the Elderly Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chronic Disease Management Services for the Elderly Sales Value Share by Country, 2025 VS 2032
7 Chronic Disease Management Services for the Elderly Country-level Value Analysis
  1. 7.1 Global Chronic Disease Management Services for the Elderly Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chronic Disease Management Services for the Elderly Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chronic Disease Management Services for the Elderly Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chronic Disease Management Services for the Elderly Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chronic Disease Management Services for the Elderly Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chronic Disease Management Services for the Elderly Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chronic Disease Management Services for the Elderly Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ALiHealth
  2. 8.1.1 ALiHealth Company Information
  3. 8.1.2 ALiHealth Business Overview
  4. 8.1.3 ALiHealth Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ALiHealth Chronic Disease Management Services for the Elderly Product Portfolio
  6. 8.1.5 ALiHealth Recent Developments
  7. 8.2 Meinian Onehealth Healthcare
  8. 8.2.1 Meinian Onehealth Healthcare Company Information
  9. 8.2.2 Meinian Onehealth Healthcare Business Overview
  10. 8.2.3 Meinian Onehealth Healthcare Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Meinian Onehealth Healthcare Chronic Disease Management Services for the Elderly Product Portfolio
  12. 8.2.5 Meinian Onehealth Healthcare Recent Developments
  13. 8.3 Pingan Health
  14. 8.3.1 Pingan Health Company Information
  15. 8.3.2 Pingan Health Business Overview
  16. 8.3.3 Pingan Health Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pingan Health Chronic Disease Management Services for the Elderly Product Portfolio
  18. 8.3.5 Pingan Health Recent Developments
  19. 8.4 CIMING CHEKUP
  20. 8.4.1 CIMING CHEKUP Company Information
  21. 8.4.2 CIMING CHEKUP Business Overview
  22. 8.4.3 CIMING CHEKUP Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CIMING CHEKUP Chronic Disease Management Services for the Elderly Product Portfolio
  24. 8.4.5 CIMING CHEKUP Recent Developments
  25. 8.5 HealthSnap
  26. 8.5.1 HealthSnap Company Information
  27. 8.5.2 HealthSnap Business Overview
  28. 8.5.3 HealthSnap Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HealthSnap Chronic Disease Management Services for the Elderly Product Portfolio
  30. 8.5.5 HealthSnap Recent Developments
  31. 8.6 ExlService Holdings
  32. 8.6.1 ExlService Holdings Company Information
  33. 8.6.2 ExlService Holdings Business Overview
  34. 8.6.3 ExlService Holdings Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ExlService Holdings Chronic Disease Management Services for the Elderly Product Portfolio
  36. 8.6.5 ExlService Holdings Recent Developments
  37. 8.7 Health Catalyst
  38. 8.7.1 Health Catalyst Company Information
  39. 8.7.2 Health Catalyst Business Overview
  40. 8.7.3 Health Catalyst Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Health Catalyst Chronic Disease Management Services for the Elderly Product Portfolio
  42. 8.7.5 Health Catalyst Recent Developments
  43. 8.8 AllScripts Healthcare Solutions
  44. 8.8.1 AllScripts Healthcare Solutions Company Information
  45. 8.8.2 AllScripts Healthcare Solutions Business Overview
  46. 8.8.3 AllScripts Healthcare Solutions Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AllScripts Healthcare Solutions Chronic Disease Management Services for the Elderly Product Portfolio
  48. 8.8.5 AllScripts Healthcare Solutions Recent Developments
  49. 8.9 Koninklijke Philips
  50. 8.9.1 Koninklijke Philips Company Information
  51. 8.9.2 Koninklijke Philips Business Overview
  52. 8.9.3 Koninklijke Philips Chronic Disease Management Services for the Elderly Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Koninklijke Philips Chronic Disease Management Services for the Elderly Product Portfolio
  54. 8.9.5 Koninklijke Philips Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst